Financial report interval: 2025.07.01 - 2025.12.31
Preview: SKB BIO(06990) predict that the Revenue is 1.107 B (+89.19%), Beat estimate;the EBIT is -290.55 M (+50.39%), Beat estimate;the EPS is -1.16 (+61.02%), Beat estimate.